CAC
EVH icon

Cowen and Company’s Evolent Health EVH Stock Holding History

Cowen and Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$283K – 118
2024
Q3 		$283K Buy
+10,000
New +$258K 0.01% 210

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Cowen and Company's EVH Position: Q4 2024 in Review

Cowen and Company sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 10,000 shares — an estimated $283K sold.

Cowen and Company first reported a position in EVH in Q3 2024 and held it in 1 quarter. The position peaked at $283K in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Cowen and Company reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 10,000 Evolent Health shares in Q4 2024, an estimated $283K.
  • Cowen and Company first reported a position in Evolent Health in Q3 2024 and held it in 1 quarter.
  • Cowen and Company's Evolent Health position peaked at $283K in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.